Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Jusung Engineering (036930) – Holding of Investor Relations (IR) / 2024-08-16

Posted on August 16, 2024August 3, 2026 By K-STOCK Editor No Comments on [Disclosure] Jusung Engineering (036930) – Holding of Investor Relations (IR) / 2024-08-16

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Jusung Engineering will hold a domestic NDR for institutional investors and analysts from August 19 to 20 via 1-on-1 meetings to discuss H1 2024 earnings commentary and business operations.

📊 [Key Disclosure Contents & Major Figures Summary]

  • Disclosure Title: Holding of Investor Relations (IR)
  • Event Period: 2024-08-19 to 2024-08-20 (09:00 – 17:00 Local Time)
  • Location: Seoul (Yeouido, Jongno, etc.)
  • Target Audience: Domestic and foreign institutional investors, securities firm analysts, etc.
  • Purpose: Domestic NDR (Enhancing investor understanding of the company’s technology and business strategy)
  • Format: 1-on-1 face-to-face meetings
  • Key Contents:
    • Commentary on H1 2024 financial results
    • Overview of major business status and Q&A session
  • Sponsoring Institution: Daol Investment & Securities Co., Ltd.
  • Date of Confirmation: 2024-08-07
  • Posting of IR Materials:
    • Date & Time: 2024-08-16
    • Location: Company website (https://www.jusung.com/board/irmaterials) and KRX KIND system (http://kind.krx.co.kr)

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Published IR Materials and H1 Earnings Commentary

This disclosure notifies the market that the company is holding 1-on-1 NDR meetings for institutional investors to present commentary on its H1 2024 financial results and major business status. Reviewing the official IR materials published on the company’s website and the KRX KIND system is important for verifying the official H1 2024 financial results commentary and major business updates regarding the event. Details can be verified directly through the IR materials section of Jusung Engineering’s official website and the KRX KIND system.

📢 Disclaimer & Source Notice

Source: This content has been re-structured and authored based on official data submitted to the Financial Supervisory Service’s DART system.

Investment Risk Warning: This material is provided strictly for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest entirely with the individual investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] Jusung Engineering (036930) – Holding of Investor Relations (IR) / 2024-08-16
Next Post: [Disclosure] Hanwha Aerospace (012450) – Market Measures Notice for Stock Futures/Options Due to Corporate Spin-off: Expiry Date Moved to August 28, 2024

Related Posts

[Disclosure] Hana Micron (067310) – Investor Relations (IR) Holding / 2025-03-06 Semiconductors
[Disclosure] Samsung Electronics(005930) – Provisional Consolidated Financial Performance (Fair Disclosure) / 2024-01-31 Disclosures
[Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2025-09-17 Disclosures
[Disclosure] SK Square (402340) – Decision on New Facility Investment / 2024-04-24 Semiconductors
[Disclosure] Hanwha Ocean (042660) – Correction of Decision on Monetary Loan / 2025-01-08 Disclosures
[Disclosure] Hanwha Aerospace (012450) Announces Corporate Investor Relations (IR) Event for Domestic Institutional Investors to Discuss Q3 2025 Performance and Outlook Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme